You are here:

lopinavir 200 mg, ritonavir 50 mg tablet (Kaletra)

Advice

Following an abbreviated submission

Lopinavir 200 mg, ritonavir 50 mg tablet (Kaletra) is accepted for use in NHS Scotland for the treatment of HIV-1 infected adults and children above the age of 2 years, in combination with other antiretroviral agents.

For patients for whom this drug combination is appropriate, it is associated with a reduced pill burden compared to an existing solid oral dose formulation containing these drugs at no increased cost.

Drug Details

Drug Name: lopinavir 200 mg, ritonavir 50 mg tablet (Kaletra)
SMC Drug ID: 326/06
Manufacturer: Abbott Laboratories Limited
Indication: HIV-1
BNF Category:
Sub Category: 5.3 Antiviral Drugs
Submission Type: Abbreviated Submission
Status: Accepted
Date Advice Published: 13 November 2006

Back